The global catheter market size was worth USD 48 billion in 2021. It is estimated to reach USD 88 billion by 2030, growing at a CAGR of 6.8% during the forecast period (2022–2030). Medical catheters are tubes that can be put into a body cavity, vessel, or duct, typically to administer fluids, drugs, or gases or drain fluids or urine from the body. Catheters can also be used to perform all of these functions simultaneously. Intravenous catheters, urinary catheters, and chest drainage tubes are all examples of the various types of catheters that are available. It is possible to utilize catheters to drain fluid and pus accumulated in cavities. For instance, they may be used in the process of aspirating pus from an abdominal abscess. To administer fluids and medications intravenously, catheters are typically employed.
There are many categories of catheters, including those designed specifically for cardiovascular, neurovascular, urology, and specialty applications. Catheters are typically only required for a short time, such as for a few weeks or months when continuous bladder drainage is necessary. However, in some instances, they are required for more extended periods. The market's expansion has been driven mainly by the high prevalence rate of chronic disorders that result in hospitalization.
In addition, during the forecast period, the market is anticipated to expand due to an increasing propensity among midscale catheter manufacturers to acquire a larger market share and an increase in the funding by various government bodies for research and development activities. Both of these factors will likely aid the global catheter market's growth.
Get more information on this report Download Sample Report
Catheterization is necessary for patients who voluntarily undergo elective surgeries while under general anesthesia. Infections of the urinary tract caused by catheters, known as catheter-associated urinary tract infections (CAUTIs), and infections of the bloodstream caused by central lines, known as CLABSIs, can be caused by frequent use of catheters (CLABSIs).
Patients with chronic conditions typically have a compromised immune system, and catheters are routinely inserted into their blood vessels, increasing their risk of contracting an infection. Hence, more businesses are concentrating their efforts on developing antimicrobial catheters to lower the risk of thrombosis and infections associated with catheter use. Market players are introducing new features to catheters to address the growing problems related to using catheters. Hence, driving the demand for antimicrobial catheters.
In the last three decades, cardiovascular, urologic, and neurological diseases have emerged as some of the most significant contributors to morbidity and mortality rates worldwide. People who lead a sedentary lifestyle are at a greater risk of developing various chronic conditions, including diabetes, cardiovascular diseases (CVDs), urologic disorders (including end-stage renal disease or ESRD), and others. High blood pressure and diabetes are significant contributors to the rising incidence of chronic diseases like kidney failure, one of the most severe consequences of this trend. Most kidney disorders are brought on by conditions such as urinary tract infections, glomerulonephritis, polycystic kidney disease, lupus, and other kidney malformations.
Several factors contribute to an increase in cardiovascular and neurovascular diseases, including poor lifestyle choices, such as insufficient physical activity, excessive consumption of alcohol, smoking cigarettes, obesity, and dietary inconsistencies. As these diseases become common, more people will need to use catheters, driving demand throughout the forecast period. Furthermore, end-stage renal disease is associated with high hospitalization rates and substantial costs because its treatment requires dialysis catheters. It is anticipated that rising hospitalization rates brought on by an increase in the prevalence of chronic disorders will boost the adoption of catheters, which will, in turn, drive market growth.
Catheters are linked to vein thrombosis, which can result in pulmonary embolism and, in extreme cases, can be fatal. Catheters also increase the risk of infection. Patients who have undergone catheter insertions are at an increased risk of complications associated with catheter-related bloodstream infections (CABSI) due to repeated catheter use. This risk can also lead to an increased incidence of catheter-related bloodstream infections. Patients who have undergone catheter insertions have been found to have an increased incidence of catheter-related bloodstream infection and associated complications and risks as a result of the repeated use of catheters.
The production of catheters is carried out by companies employing cutting-edge materials such as polyurethanes and polycarbonates. Sorbothane, which is resistant to chemicals such as iodine, hydrogen peroxide, or alcohol, is used in the manufacturing process of catheters to increase the longevity of the devices. Additionally, catheters made of Durathane offer both resistance and strength to the user.
For instance, Angio Dynamics's DuraFlow 2 chronic hemodialysis catheter is made of a material called Durathane, which has properties similar to those of both silicone and polyurethane and thus combines the benefits of both. The material used in this catheter provides strength and is resistant to a variety of site care agents that are commonly used. Therefore, the utilization of advanced materials in the production of catheters is anticipated to result in an increase in demand from end-users in the years to come.
The global catheter market share is segmented across product and end-user.
Product-wise, the global catheter market has been classified into Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, and Specialty Catheters.
Cardiovascular Catheters are expected to dominate the market, growing at a CAGR of 6.9% by 2030. During cardiac catheterization, cardiovascular catheters are typically utilized. Patients suffering from heart conditions and myocardial infarctions can benefit from the coronary catheterization procedure with the assistance of these catheters. It is anticipated that the growing prevalence of cardiovascular disorders, the rising demand for interventional cardiac procedures, and the rising adoption of cardiac catheters will contribute to the expansion of the market for cardiovascular catheters throughout the forthcoming period. Due to the rising prevalence of cardiac conditions like coronary artery disease, congenital heart problems, and cardiac arrhythmia, there has been an uptick in demand for these catheters.
Specialty Catheter is the fastest-growing segment and is anticipated to be driven by the increasing demand for minimally invasive procedures and the rising prevalence of target diseases.
End-user-wise, the global catheter market has been classified into Hospital Stores, Retail Stores, and Others.
Hospital Stores will command the largest market share during the forecast period, growing at a CAGR of 6.7%. This can be attributed to a rise in hospital admission rates worldwide and an increase in surgical procedures requiring catheter infusion of IV solutions and fluids. A hospital store/pharmacy stores and dispenses in-patient medications within a hospital. Typically, hospital pharmacies stock a vast assortment of medications, including more specialized and investigational medications, thereby contributing to the segment's growth. The increasing incidence and prevalence of cardiovascular, neurologic, and urologic disorders and the rising number of minimally invasive procedures contribute to expanding the hospital supplies market.
Region-wise, the global catheter market share has been segmented across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Regional Growth Insights Request Sample Pages
North America acquires the largest share and is expected to grow at a CAGR of 6.5% by 2030. The North American market for catheters and medical supplies is the most developed. The rising prevalence of chronic disorders, supportive government policies, growing awareness, the availability of qualified, skilled physicians, and well-established healthcare facilities all contribute to regional growth. In addition, expanding private research funding for research and development activities of innovative devices positively influences the market expansion in this region.
An increase in lifestyle-related chronic diseases and well-established healthcare infrastructure are additional factors driving market expansion. Moreover, an increment in the number of patients undergoing surgical procedures and a heightened awareness of minimally invasive procedures is also responsible for the market expansion in North America. The presence of a well-established regulatory framework also positively influences the expansion of the catheter market. Through Health Canada's Special Access Program, the Canada Revenue Agency (CRA) offers tax deductions for catheters.
Europe is expected to be the second-largest region, expanding at a CAGR of 6.9% to reach USD 26,312 million by 2030. Due to an increase in the number of catheter-offering medical equipment companies in Europe, the continent's robust healthcare system has shifted from in-patient to out-patient care. The rising geriatric population in search of better healthcare facilities and increasing patient interest in minimally invasive procedures are expected to significantly impact market growth. The rapidly expanding elderly population with chronic conditions such as incontinence, peripheral vascular disease, and cardiac issues and the European population's reliance on government-funded healthcare services are anticipated to positively influence the growth of the catheters market in this region.
Favorable government policies issued by the National Institute for Health and Care Excellence will facilitate catheter device accessibility. In February of 2020, for instance, the United Kingdom introduced a bill titled "Medicines and Medical Device 2019-20" to revise its regulatory framework for clinical trials, medical devices, and human and veterinary medicines. However, a lack of awareness may hinder the expansion of the market.
Asia-Pacific is the fastest-growing region. This is attributable to the prevalence of kidney and cardiovascular diseases, improved medical facilities, and the availability of insurance policies. China and India are the major growth engines in Asia-Pacific, while Japan's population is rapidly aging. In addition, China and India are anticipated to experience the most rapid growth during the forecast period. However, shortages of nephrologists and cardiac surgeons may hinder market expansion.
|Market Size||USD in Billion By 2030|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
|Segments Covered||by Product (Cardiovascular Catheters, Urology Catheters, Intravenous Catheters), End-User (Hospital Stores, Retail Stores)|
|Geographies Covered||North America, Europe, Asia-Pacific, LAME and Rest of the World|
|Key Companies Profiled/Vendors||Medtronic, Convatec Corporation, Smiths Medical, Inc., Boston Scientific Corporation, Coloplast Corporation, Edwards Lifesciences Corporation,|
|Key Market Opportunities||Growing Prevalence Of Medical Devices Industry Helps To Grow Catheter Market Share|